Follow-up comparison Pharmacokinetics study for ND0701
Phase of Trial: Phase I
Latest Information Update: 30 Mar 2017
At a glance
- Drugs Apomorphine (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions
- 30 Mar 2017 According to a NeuroDerm media release, this trial is expected to initiate in the second half of 2017.
- 08 Dec 2016 New trial record
- 02 Dec 2016 According to a NeuroDerm media release, this trial is expected to initiate in the first half of 2017.